MG
DGX icon

Marex Group’s Quest Diagnostics DGX Stock Holding History

Marex Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$382K Buy
+1,801
New +$353K ﹤0.01% 783
2025
Q4 		– Sell
-1,500
Closed -$286K – 1014
2025
Q3 		$286K Hold
1,500
– – ﹤0.01% 636
2025
Q2 		$269K Hold
1,500
– – ﹤0.01% 469
2025
Q1 		$254K Buy
+1,500
New +$246K ﹤0.01% 505

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Marex Group's DGX Position: Q2 2026 in Review

Marex Group opened a new position in Quest Diagnostics (DGX) in Q2 2026: 1,801 shares worth $382K. The stake represents ﹤0.01% of the portfolio and ranks #783 among its holdings. This is a return to the name: Marex Group previously reported a position in DGX as recently as Q3 2025.

Marex Group first reported a position in DGX in Q1 2025 and has held it in 4 quarters since. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Marex Group held 1,801 shares of Quest Diagnostics worth $382K as of Q2 2026.
  • Quest Diagnostics was a new Marex Group position in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #783 holding.
  • Marex Group first reported a position in Quest Diagnostics in Q1 2025 and has held it in 4 quarters since.
  • 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.